Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug:199:108607.
doi: 10.1016/j.maturitas.2025.108607. Epub 2025 May 23.

Persistent gaps in menopause care: current recommendations of the POESIT group

Affiliations
Free article
Review

Persistent gaps in menopause care: current recommendations of the POESIT group

Costantino Di Carlo et al. Maturitas. 2025 Aug.
Free article

Abstract

In recent years, menopause awareness has been increasing in several European countries; however, gaps in menopause knowledge, attitudes and practices persist. This review provides an overview of the women's current menopausal experience in Italy, Spain and Portugal, and gives POESIT (Portugal + Spain + Italy) group recommendations to address persistent barriers in menopause care. The perception, occurrence and impact of menopause symptoms vary among countries, with genitourinary syndrome of menopause and vasomotor symptoms being the most frequent overall. Sexuality seems to be particularly affected by menopause, mostly due to genitourinary syndrome of menopause. Nonetheless, women's knowledge about the diverse range of menopause symptoms and their therapies is still poor. The importance of menopause hormone therapy for quality of life and prevention of chronic conditions, such as osteoporosis, is underestimated and its use remains generally low, likely due to women's view of menopause as a natural condition not requiring treatment, and common misconceptions and fears about side-effects (mostly cancer). The lack of knowledge and training about menopause symptoms and treatment indications among healthcare professionals represents another important barrier to providing suitable personalized care to women. The POESIT group highlights the need to raise public knowledge about menopause and its symptoms to improve care for women during and after menopausal transition. Policymakers and scientific societies should be actively involved to address treatment barriers. The POESIT group advocates the improvement of education among healthcare professionals to foster a personalized approach to menopause care.

Keywords: Education; Genitourinary syndrome of menopause; Menopause; Menopause hormone therapy; Policy; Vasomotor symptoms.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest C.D.C.: lecturer and member of the Advisory Board for Theramex, Gedeon-Richter, Exeltis, Bayer, Italfarmaco and Shionogi. A.C.: lecturer and member of the Advisory Board for Theramex, Gedeon-Richter, Organon, Exeltis, Bayer, Italfarmaco and Shionogi. M.G.: lecturer and member of the Advisory Board for Theramex, Fotona, Ganassini, Organon, Bayer, and Shionogi. S.P.: symposium speaker or Advisory Board member for: Bayer, Theramex, Novo Nordisk, Gedeon Richter, Exeltis, Besins, Procaps, Procare, Serelys, Shionogi, Otsuka and Idorsia. Research grants and/or consulting fees from: Sandoz, Theramex, Amgen, Bayer Schering, Gedeon Richter, Exeltis, Procare. C.R.: lecturer and member of the Advisory Board for Theramex, Gedeon-Richter, Organon, MSD, Bayer and Biocodex. P.C.: lecturer and/or member of the Advisory Board for Theramex, Shionogi, Astellas, Novonordisk, Procareh, Abex, MSD, Organon and Adventia. J.P.: lecturer and/or member of the Advisory Board for Astellas, Theramex, Gynea-Kern, Novonordisk, Amgen and Gedeon Richter. S.S.: lecturer and/or member of the Advisory Board for Theramex, Shionogi, Astellas, Novonordisk, Organon, Isdin, DermoLab, Menarini, Kern and Gedeon Richter. A.F.: lecturer and/or member of the Advisory Board for MSD, Tecnimed, Theramex and Bayer Portugal. M.G.F.: lecturer and member of the Advisory Board for Biocodex, key opinion leader for INMODE, royalties from SPRINGER NATURE. R.E.N.: past financial relationships (lecturer, member of advisory boards and/or consultant) with Boehringer Ingelheim, Eli Lilly, Endoceutics, HRA Pharma, Novo Nordisk, Palatin Technologies, Pfizer, Procter & Gamble, Teva Women's Health and Zambon; ongoing relationships with Abbott, Astellas, Bayer HealthCare, Besins Healthcare, Biocodex, Exeltis, Fidia, Gedeon Richter, Merck & Co, Organon, Shionogi, Theramex, Viatris and Vichy Laboratories, and serves as President of the International Menopause Society.

LinkOut - more resources